Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Read more
about ABIVAX S.A. - 2025/07/23
$747.4 Million
Image
ABIVAX
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Nektar Therapeutics - 2025/06/30
$100.0 Million
Image
Nektar Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Inovio Pharmaceuticals, Inc. - 2025/07/02
$25.0 Million
Image
Inovio Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Taysha Gene Therapies - 2025/05/28
$200.0 Million
Image
Taysha Gene Therapies
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about CytomX Therapeutics Inc. - 2025/05/20
Image
CytomX Therapeutics Inc.
Follow-On Offering
Co-Manager
Read more
about CytomX Therapeutics Inc. - 2025/05/12
$100.0 Million
Image
CytomX Therapeutics Inc.
Underwritten Registered Direct Offering
Active Bookrunner
Read more
about Edgewise Therapeutics - 2025/04/02
$200.0 Million
Image
Edgewise Therapeutics
Follow-on
Active Bookrunner
Piper Sandler Expands Healthcare Investment Banking Team with the Addition of Christian Draisbach
Christian
Draisbach
Managing Director, Healthcare
Read more
about Altimmune - 2025/02/27
$150.0 Million
Image
Altimmune
ATM Program Common Stock
Sole Placement Agent
Pagination
Previous page
‹‹
Page 3
Next page
››
Subscribe to Biopharma
